Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Methionine 1件: Methionine3件: Butanoic acid; L-methionine; Methionine; --7件: 34, 75, 84, 93, 229, 298, 300
2 Maltose 1件: Maltose1件: Maltose; --2件: 96, 97
3 Mannitol 1件: Mannitol4件: Aridol; Bronchitol; Mannite; Mannitol; --7件: 6, 13, 28, 60, 96, 113, 299
4 Microcrystalline cellulose 1件: Microcrystalline cellulose1件: Cellulose; --4件: 35, 53, 96, 162
5 Menatetrenone 1件: Menatetrenone1件: Menatetrenone; --1件: 66
6 Methoxsalen 1件: Methoxsalen2件: Methoxsalen; UVADEX; --4件: 36, 46, 51, 96
7 Methotrexate 1件: Methotrexate6件: Methotrexat; Methotrexate; METHOTREXATE SODIUM; METOJECT; Metotrexato; Méthotrexate; 2件: DHFR,
DHFR2 💬
5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
8 Mefenamic acid -0件: ---
9 Mercaptopurine 1件: Mercaptopurine4件: 6-Mercaptopurine; 6-MP; Mercaptopurine; PURINETHOL; 1件: HPRT1 💬3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬4件: 65, 96, 97, 164
10 Meclofenamate sodium -0件: ---
11 Mitomycin 1件: Mitomycin2件: Mitomycin; Mitomycin C; --3件: 94, 118, 329
12 Metoprine -0件: ---
13 Mazindol -0件: ---
14 Mebendazole -0件: ---
15 Melphalan 1件: Melphalan3件: ALKERAN; MELPHALAN; Melphalan Hydrochloride; --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
16 Mephenytoin -0件: ---
17 Meprobamate -0件: ---
18 Mesalamine 1件: Mesalazine10件: 5-Aminosalicylic acid; 5-ASA; ASACOL; Mesalamine; MESALAZINA; Mesalazine; Mesalazinum; MEZAVANT; Pentasa; Salofalk; --4件: 46, 96, 97, 164
19 Metandienone -0件: ---
20 Methenamine -0件: ---
21 Methimazole 1件: Methimazole1件: Methimazole; 1件: TPO 💬4件: Autoimmune thyroid disease, Metabolic pathways, Thyroid hormone synthesis, Tyrosine metabolism 💬1件: 50
22 Methocarbamol -0件: ---
23 Methotrimeprazine -0件: ---
24 Methsuximide -0件: ---
25 Methyldopa 1件: Methyldopa1件: Methyldopa; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 323
26 Methylprednisolone 1件: Methylprednisolone4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
27 Methyltestosterone -0件: ---
28 Metronidazole 1件: Metronidazole3件: Flagyl; Metronidazol; Metronidazole; --8件: 46, 51, 63, 94, 95, 96, 97, 291
29 Metyrapone 1件: Metyrapone2件: Metopirone; Metyrapone; 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬2件: 75, 193
30 Miconazole -0件: ---
31 Milrinone 1件: Milrinone1件: Milrinone; 2件: PDE3A,
PDE3B 💬
11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 294
32 Minoxidil 1件: Minoxidil1件: MINOXIDIL; 2件: ABCC8,
KCNJ11 💬
4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 179
33 Misoprostol 1件: Misoprostol1件: Misoprostol; 3件: PTGER2,
PTGER3,
PTGER4 💬
9件: Calcium signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway 💬3件: 46, 70, 271
34 Mitotane -0件: ---
35 Metolazone -0件: ---
36 Montelukast sodium 1件: Montelukast3件: Montelukast; MONTELUKAST SODIUM; Singulair; 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬8件: 6, 13, 46, 61, 63, 85, 98, 228
37 Malathion -0件: ---
38 Methoxyflurane -0件: ---
39 Midazolam 1件: Midazolam2件: Midazolam; Midazolam injection; 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298
40 Methaqualone -0件: ---
41 Mirtazapine -0件: ---
42 Mestranol 1件: Mestranol1件: Ortho-novum; 2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 46, 49
43 Mifepristone 1件: Mifepristone1件: MIFEPRISTONE; 2件: NR3C1,
PGR 💬
6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75
44 Metoprolol tartrate 1件: Metoprolol2件: Metoprolol; METOPROLOL SUCCINATE; 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226
45 Mecamylamine hydrochloride -0件: ---
46 Moexipril hydrochloride 1件: Moexipril1件: Moexipril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 93
47 Miglitol -0件: ---
48 Mexiletine hydrochloride 1件: Mexiletine4件: Mexiletina; Mexiletine; Mexitil; Namuscla; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114
49 Methazolamide -0件: ---
50 Methyclothiazide -0件: ---
51 Methylergonovine maleate 1件: Methylergometrine0件: 6件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 118, 280, 288
52 Methysergide maleate -0件: ---
53 Metaproterenol sulfate -0件: ---
54 Mometasone furoate 2件: Mometasone,
Mometasone furoate
3件: Mometasone; Mometasone furoate; Nasonex; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 98, 98, 162, 162
55 Midazolam hydrochloride 1件: Midazolam2件: Midazolam; Midazolam injection; 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298
56 Mephobarbital -0件: ---
57 Methohexital sodium -0件: ---
58 Methscopolamine bromide -0件: ---
59 Methanthelinium bromide -0件: ---
60 Metoclopramide 1件: Metoclopramide1件: METOCLOPRAMIDE; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51
61 Magnesium hydroxide 1件: Magnesium hydroxide1件: Magnesium hydroxide; --1件: 284
62 Mepivacaine hydrochloride -0件: ---
63 Methylprednisolone sodium succinate 1件: Methylprednisolone4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
64 Mycophenolate mofetil 1件: Mycophenolate mofetil3件: CellCept; Mycophenolate mofetil; Mycophenolate mofetil TEVA; 2件: IMPDH1,
IMPDH2 💬
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
65 Metocurine iodide -0件: ---
66 Metyrosine -0件: ---
67 Mivacurium chloride -0件: ---
68 Metaxalone -0件: ---
69 Mesoridazine besylate -0件: ---
70 Metrifonate -0件: ---
71 Maprotiline hydrochloride -0件: ---
72 Magnesium salicylate -0件: ---
73 Melarsoprol 1件: Melarsoprol1件: Melarsoprol; --1件: 65
74 Morphine sulfate 1件: Morphine2件: Morphine; MORPHINE SULFATE; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬6件: 36, 46, 70, 85, 86, 298
75 Minocycline hydrochloride 1件: Minocycline3件: Minocycline; Minocycline hydrochloride; Minomycin; --14件: 2, 6, 8, 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299
76 Mercurochrome -0件: ---
77 Moxifloxacin hydrochloride 1件: Moxifloxacin2件: Moxifloxacin; Moxifloxacin hydrochloride; --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
78 Miconazole nitrate -0件: ---
79 Metformin hydrochloride 1件: Metformin5件: METFORMIN; Metformin HCl; Metformin Hydrochloride; METFORMINA; Metformine; 2件: PRKAA1,
PRKAA2 💬
20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
80 Medroxyprogesterone acetate 1件: Medroxyprogesterone acetate1件: Medroxyprogesterone; 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬6件: 13, 35, 46, 49, 51, 60
81 Megestrol acetate 1件: Megestrol acetate1件: Megestrol acetate; 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76
82 Meloxicam 1件: Meloxicam1件: Meloxicam; 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 46, 49, 271, 296
83 Methylprednisolone acetate 1件: Methylprednisolone4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
84 Meclofenoxate -0件: ---
85 Metaraminol bitartrate -0件: ---
86 Methoxamine hydrochloride -0件: ---
87 Mupirocin 1件: Mupirocin1件: Mupirocin; --2件: 227, 299
88 Methylatropine nitrate 1件: Atropine2件: Atropina; Atropine; 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 2, 299
89 Methyl salicylate -0件: ---
90 Maxacalcitol -0件: ---
91 Magnesium sulfate 1件: Magnesium sulfate1件: Magnesium sulfate; --3件: 11, 296, 297
92 Mizolastine -0件: ---
93 Methyprylon -0件: ---
94 Magnesium oxide 1件: Magnesium oxide1件: Magnesium Oxide; --3件: 6, 166, 291
95 Medazepam -0件: ---
96 Methylphenidate hydrochloride 1件: Methylphenidate3件: Methylphenidate; METHYLPHENIDATE HYDROCHLORIDE; Ritalin; 2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206
97 Midodrine hydrochloride 1件: Midodrine2件: Midodrine; MIDODRINE HYDROCHLORIDE; 3件: ADRA1A,
ADRA1B,
ADRA1D 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 6, 17, 58
98 Metrizamide -0件: ---
99 Mexazolam -0件: ---
100 Meclizine hydrochloride -0件: ---
101 Molsidomine -0件: ---
102 Mequitazine -0件: ---
103 Midecamycin -0件: ---
104 Metharbital -0件: ---
105 Meperidine hydrochloride 1件: Meperidine1件: Pethidine; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 298
106 Mizoribine 1件: Mizoribine2件: BREDININ; Mizoribine; 2件: IMPDH1,
IMPDH2 💬
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬8件: 46, 49, 51, 53, 66, 94, 222, 224
107 Methyl parahydroxybenzoate -0件: ---
108 Magnesium carbonate -0件: ---
109 Methyl L-cysteine hydrochloride -0件: ---
110 Meticrane -0件: ---
111 Midecamycin acetate -0件: ---
112 Meglumine 1件: Meglumine1件: Meglumine; --2件: 28, 53
113 Mebutamate -0件: ---
114 Modafinil 1件: Modafinil2件: Modafinil; Provigil; --5件: 6, 13, 49, 93, 113
115 Mitiglinide calcium hydrate -0件: ---
116 Methixene hydrochloride -0件: ---
117 Mefruside -0件: ---
118 Mercuric chloride -0件: ---
119 Mitobronitol -0件: ---
120 Magnesium L-aspartate 1件: Magnesium aspartate1件: Magnesium aspartate; --1件: 298
121 Metipranolol hydrochloride -0件: ---
122 Milrinone lactate 1件: Milrinone1件: Milrinone; 2件: PDE3A,
PDE3B 💬
11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 294
123 Methadone hydrochloride -0件: ---
124 Methotrexate sodium 1件: Methotrexate6件: Methotrexat; Methotrexate; METHOTREXATE SODIUM; METOJECT; Metotrexato; Méthotrexate; 2件: DHFR,
DHFR2 💬
5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
125 Mitoxantrone hydrochloride 1件: Mitoxantrone2件: Mitoxantrone; Novantrone; 2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13
126 Magnesium stearate -0件: ---
127 Mupirocin calcium 1件: Mupirocin1件: Mupirocin; --2件: 227, 299
128 Metoclopramide hydrochloride 1件: Metoclopramide1件: METOCLOPRAMIDE; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51
129 Mezlocillin sodium -0件: ---
130 Meropenem 1件: Meropenem1件: MEROPENEM; --2件: 60, 299
131 Morphine hydrochloride hydrate 1件: Morphine2件: Morphine; MORPHINE SULFATE; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬6件: 36, 46, 70, 85, 86, 298
132 Medrysone -0件: ---
133 Methylene blue 1件: Methylene blue2件: Methylene blue; Methylthioninium chloride; --3件: 46, 97, 127
134 Maltodextrin 1件: Maltodextrin1件: Maltodextrin; --4件: 6, 13, 96, 97
135 Menadione -0件: ---
136 Meclofenamic acid -0件: ---
137 Mafenide -0件: ---
138 Methysergide -0件: ---
139 Metoprolol 1件: Metoprolol2件: Metoprolol; METOPROLOL SUCCINATE; 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226
140 Metipranolol -0件: ---
141 Micafungin sodium -0件: ---
142 Meclocycline -0件: ---
143 Miltefosine -0件: ---
144 Methisazone -0件: ---
145 Mepacrine dihydrochloride 1件: Quinacrine1件: Quinacrine; --1件: 23
146 Moclobemide 1件: Moclobemide1件: MOCLOBEMIDE; 1件: MAOA 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
147 Maprotiline -0件: ---
148 Metildigoxin -0件: ---
149 Mephenesin -0件: ---
150 Moperone -0件: ---
151 Mesoridazine -0件: ---
152 Menotropins -0件: ---
153 Mecobalamin 1件: Mecobalamin2件: Mecobalamin; Methylcobalamin; --2件: 2, 70
154 Magnesium citrate 1件: Magnesium citrate1件: Magnesium citrate; --1件: 97
155 Magnesium trisilicate -0件: ---
156 Mecasermin 1件: Mecasermin3件: Increlex; Mecasermin; MECASERMINA; 2件: GHR,
IGF1R 💬
33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬6件: 65, 78, 96, 168, 265, 299
157 Mometasone furoate hydrate 1件: Mometasone1件: Mometasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162
158 Marimastat -0件: ---
159 Mubritinib -0件: ---
160 Maduramicin -0件: ---
161 Magaldrate -0件: ---
162 Magnesium aluminum silicate -0件: ---
163 Magnesium chloride -0件: ---
164 Magnesium gluconate 1件: Magnesium gluconate2件: Magnesium; Magnesium gluconate; --2件: 296, 297
165 Magnesium phosphate -0件: ---
166 Magnesium silicate -0件: ---
167 Malic acid -0件: ---
168 Manganese gluconate -0件: ---
169 Maribavir -0件: ---
170 Masoprocol -0件: ---
171 Mebrofenin -0件: ---
172 Mecasermin rinfabate 1件: Mecasermin3件: Increlex; Mecasermin; MECASERMINA; 2件: GHR,
IGF1R 💬
33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬6件: 65, 78, 96, 168, 265, 299
173 Mechlorethamine hydrochloride -0件: ---
174 Medrogestone -0件: ---
175 Medronic acid -0件: ---
176 Mefloquine 1件: Mefloquine2件: Lariam; MEFLOQUINE; --2件: 25, 46
177 Meglutol -0件: ---
178 Melengestrol acetate -0件: ---
179 Memantine hydrochloride 1件: Memantine3件: EBIXA; Memantine; Memantine hydrochloride; 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬7件: 2, 6, 8, 13, 49, 127, 205
180 Menadiol sodium diphosphate 1件: Kappadione1件: Menadiol sodium diphosphate; --1件: 299
181 Meningococcal polysaccharide vaccine group A 1件: Meningococcal polysaccharide vaccine group A2件: Menveo; Nimenrix; --7件: 11, 13, 50, 61, 62, 66, 222
182 Menthol -0件: ---
183 Mepartricin -0件: ---
184 Mepolizumab 1件: Mepolizumab2件: Mepolizumab; NUCALA; 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬4件: 44, 45, 98, 162
185 Mequinol -0件: ---
186 Meradimate -0件: ---
187 Mercaptopurine 1件: Mercaptopurine4件: 6-Mercaptopurine; 6-MP; Mercaptopurine; PURINETHOL; 1件: HPRT1 💬3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬4件: 65, 96, 97, 164
188 Mercury, ammoniated -0件: ---
189 Merimepodib -0件: ---
190 Mesterolone -0件: ---
191 Metacresol -0件: ---
192 Metformin 1件: Metformin5件: METFORMIN; Metformin HCl; Metformin Hydrochloride; METFORMINA; Metformine; 2件: PRKAA1,
PRKAA2 💬
20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
193 Methacycline -0件: ---
194 Methadyl acetate -0件: ---
195 Methdilazine -0件: ---
196 Methdilazine hydrochloride -0件: ---
197 Methohexital -0件: ---
198 Methyl aminolevulinate hydrochloride -0件: ---
199 Methyl nicotinate -0件: ---
200 Methylcellulose 1件: Methylcellulose1件: Methyl cellulose; --1件: 53
201 Methylphenidate 1件: Methylphenidate3件: Methylphenidate; METHYLPHENIDATE HYDROCHLORIDE; Ritalin; 2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206
202 Methylprednisolone hemisuccinate 2件: Methylprednisolone,
Methylprednisolone hemisuccinate
8件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; Methylprednisolone hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone succinate; SOLU-MEDROL; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬55件: 2, 6, 11, 13, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 49, 50, 50, 51, 51, 53, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 97, 127, 145, 162, 164, 211, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
203 Methylprednisolone sodium phosphate 1件: Methylprednisolone4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
204 Methylprednisolone suleptanate 1件: Methylprednisolone4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
205 Metiamide -0件: ---
206 Metoclopramide hydrochloride 1件: Metoclopramide1件: METOCLOPRAMIDE; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51
207 Metopimazine -0件: ---
208 Metoprolol fumarate 1件: Metoprolol2件: Metoprolol; METOPROLOL SUCCINATE; 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226
209 Metreleptin 1件: Metreleptin3件: METRELEPTIN; Myalept; R-metHuLeptin; 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
210 Metronidazole hydrochloride 1件: Metronidazole3件: Flagyl; Metronidazol; Metronidazole; --8件: 46, 51, 63, 94, 95, 96, 97, 291
211 Metronidazole phosphate 1件: Metronidazole3件: Flagyl; Metronidazol; Metronidazole; --8件: 46, 51, 63, 94, 95, 96, 97, 291
212 Metyrapone tartrate 1件: Metyrapone2件: Metopirone; Metyrapone; 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬2件: 75, 193
213 Mezlocillin -0件: ---
214 Mezlocillin sodium -0件: ---
215 Mibolerone -0件: ---
216 Midazolam maleate 1件: Midazolam2件: Midazolam; Midazolam injection; 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298
217 Midostaurin -0件: ---
218 Miglustat 1件: Miglustat2件: Miglustat; Zavesca; 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
219 Minaprine -0件: ---
220 Minaprine hydrochloride -0件: ---
221 Mineral oil 1件: Mineral oil1件: Paraffin Oil; --1件: 291
222 Minocycline 1件: Minocycline3件: Minocycline; Minocycline hydrochloride; Minomycin; --14件: 2, 6, 8, 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299
223 Mirostipen -0件: ---
224 Misonidazole -0件: ---
225 Mitumomab -0件: ---
226 Molgramostim 1件: Molgramostim1件: Molgramostim; 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬3件: 97, 229, 299
227 Monensin -0件: ---
228 Monobenzone -0件: ---
229 Monoctanoin -0件: ---
230 Monoethanolamine 1件: Ethanolamine1件: Ethanolamine; --1件: 279
231 Monothioglycerol -0件: ---
232 Moricizine -0件: ---
233 Morniflumate -0件: ---
234 Motexafin gadolinium -0件: ---
235 Motexafin lutetium -0件: ---
236 Motretinide -0件: ---
237 Moxidectin -0件: ---
238 Moxonidine -0件: ---
239 Muplestim -0件: ---
240 Muraglitazar -0件: ---
241 Muromonab-CD3 1件: Muromonab3件: Anti-CD3; Muromonab; Muromonab-CD3; 3件: CD3D,
CD3E,
CD3G 💬
11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬3件: 60, 96, 97
242 Muzolimine -0件: ---
243 Mycophenolate mofetil hydrochloride 1件: Mycophenolate mofetil3件: CellCept; Mycophenolate mofetil; Mycophenolate mofetil TEVA; 2件: IMPDH1,
IMPDH2 💬
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
244 Mycophenolate sodium 1件: Mycophenolate mofetil3件: CellCept; Mycophenolate mofetil; Mycophenolate mofetil TEVA; 2件: IMPDH1,
IMPDH2 💬
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
245 Mycophenolic acid 1件: Mycophenolic acid5件: Acido Micofenolico; MICOFENOLICO ACIDO; Mycophenolate; Mycophenolic acid; Myfortic; 2件: IMPDH1,
IMPDH2 💬
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300
246 Monteplase -0件: ---
247 Mentha herb 1件: Peppermint1件: Peppermint; --1件: 226
248 Mozenavir -0件: ---
249 Meningococcal polysaccharide vaccine group C 1件: Meningococcal polysaccharide vaccine group C2件: Menveo; Nimenrix; --7件: 11, 13, 50, 61, 62, 66, 222
250 Mifamurtide -0件: ---
251 Motavizumab -0件: ---
252 Maraviroc 1件: Maraviroc1件: Maraviroc; 1件: CCR5 💬9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 84
253 Meprednisone -0件: ---
254 Motesanib -0件: ---
255 Mannosulfan -0件: ---
256 Moxaverine -0件: ---
257 Metahexamide -0件: ---
258 Melagatran -0件: ---
259 Methoserpidine -0件: ---
260 Mebutizide -0件: ---
261 Monoxerutin -0件: ---
262 Mepindolol -0件: ---
263 Methylprednisolone aceponate -0件: ---
264 Mesulfen -0件: ---
265 Metergoline -0件: ---
266 Meladrazine -0件: ---
267 Methylthiouracil -0件: ---
268 Metampicillin -0件: ---
269 Morinamide -0件: ---
270 Moroxydine -0件: ---
271 Mitoguazone -0件: ---
272 Mofebutazone -0件: ---
273 Melevodopa 1件: Melevodopa1件: Melevodopa; --1件: 6
274 Melperone 1件: Melperone1件: Melperone; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
275 Mephenoxalone -0件: ---
276 Methylpentynol -0件: ---
277 Medifoxamine -0件: ---
278 Meprotixol -0件: ---
279 Morclofone -0件: ---
280 Mepixanox -0件: ---
281 Mefenorex -0件: ---
282 Manidipine -0件: ---
283 Marbofloxacin -0件: ---
284 Mazaticol -0件: ---
285 Mebeverine -0件: ---
286 Mebhydrolin -0件: ---
287 Meclozine -0件: ---
288 Medetomidine -0件: ---
289 Medroxyprogesterone 1件: Medroxyprogesterone acetate1件: Medroxyprogesterone; 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬6件: 13, 35, 46, 49, 51, 60
290 Megestrol 1件: Megestrol acetate1件: Megestrol acetate; 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76
291 Melarsomine -0件: ---
292 Melatonin 1件: Melatonin2件: Circadin; MELATONIN; 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
293 Melitracen 1件: Melitracen1件: Melitracen; --1件: 97
294 Memantine 1件: Memantine3件: EBIXA; Memantine; Memantine hydrochloride; 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬7件: 2, 6, 8, 13, 49, 127, 205
295 Menadiol sodium sulfate 1件: Menadiol diphosphate1件: Menadiol Diphosphate; --1件: 299
296 Mepacrine 1件: Quinacrine1件: Quinacrine; --1件: 23
297 Mephentermine -0件: ---
298 Mepivacaine -0件: ---
299 Meptazinol -0件: ---
300 Mepyramine -0件: ---
301 Meropenem 1件: Meropenem1件: MEROPENEM; --2件: 60, 299
302 Metadoxine -0件: ---
303 Metamfetamine -0件: ---
304 Metamizole 1件: Metamizole1件: Metamizole; --1件: 298
305 Metaraminol -0件: ---
306 Metenolone -0件: ---
307 Methadone -0件: ---
308 Methoxamine -0件: ---
309 Methyl aminolevulinate -0件: ---
310 Methyldopa 1件: Methyldopa1件: Methyldopa; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 323
311 Methylergometrine 1件: Methylergometrine0件: 6件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 118, 280, 288
312 Metixene -0件: ---
313 Metronidazole benzoate -0件: ---
314 Mexiletine 1件: Mexiletine4件: Mexiletina; Mexiletine; Mexitil; Namuscla; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114
315 Mianserin -0件: ---
316 Mibefradil -0件: ---
317 Micafungin -0件: ---
318 Micronomicin -0件: ---
319 Midodrine 1件: Midodrine2件: Midodrine; MIDODRINE HYDROCHLORIDE; 3件: ADRA1A,
ADRA1B,
ADRA1D 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 6, 17, 58
320 Milnacipran 1件: Milnacipran1件: Milnacipran; 2件: SLC6A2,
SLC6A4 💬
2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 46, 49
321 Mitoxantrone 1件: Mitoxantrone2件: Mitoxantrone; Novantrone; 2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13
322 Moexipril 1件: Moexipril1件: Moexipril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 93
323 Molindone -0件: ---
324 Mometasone 1件: Mometasone1件: Mometasone; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162
325 Monensin -0件: ---
326 Montelukast 1件: Montelukast3件: Montelukast; MONTELUKAST SODIUM; Singulair; 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬8件: 6, 13, 46, 61, 63, 85, 98, 228
327 Moroctocog alfa -0件: ---
328 Morphine 1件: Morphine2件: Morphine; MORPHINE SULFATE; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬6件: 36, 46, 70, 85, 86, 298
329 Mosapramine -0件: ---
330 Mosapride 1件: Mosapride1件: Mosapride; 1件: HTR4 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬1件: 96
331 Moxifloxacin 1件: Moxifloxacin2件: Moxifloxacin; Moxifloxacin hydrochloride; --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
332 Moxisylyte -0件: ---
333 Mangafodipir 1件: Mangafodipir1件: Mangafodipir; --2件: 13, 58
334 Monophosphothiamine -0件: ---
335 Mersalyl -0件: ---
336 Milatuzumab 1件: Milatuzumab1件: Milatuzumab; 1件: CD74 💬3件: Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis 💬1件: 49
337 Myrrh 1件: Myrrh1件: MYRRH; --1件: 97
338 Mirabegron 1件: Mirabegron1件: Mirabegron; 1件: ADRB3 💬8件: Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬4件: 6, 13, 53, 226
339 Marizomib -0件: ---
340 Mocetinostat -0件: ---
341 Modithromycin -0件: ---
342 Mogamulizumab 1件: Mogamulizumab1件: Mogamulizumab; 1件: CCR4 💬5件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 26
343 Metildigoxin -0件: ---
344 Mavrilimumab 1件: Mavrilimumab2件: CAM-3001; Mavrilimumab; 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 41, 46
345 Mibampator -0件: ---
346 Moxetumomab pasudotox -0件: ---
347 Macitentan 1件: Macitentan2件: MACITENTAN; Opsumit; 2件: EDNRA,
EDNRB 💬
9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 51, 85, 86, 88, 210
348 Mapracorat -0件: ---
349 Masitinib 1件: Masitinib1件: MASITINIB; 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96
350 Momelotinib -0件: ---
351 Migalastat 1件: Migalastat3件: 1-Deoxygalactonojirimycin; Galafold; MIGALASTAT; --1件: 19
352 Mavatrep -0件: ---
353 Methylsamidorphan -0件: ---
354 Margetuximab -0件: ---
355 Mericitabine -0件: ---
356 Meldonium -0件: ---
357 Mebicar -0件: ---
358 Methylthioninium chloride hydrate 1件: Methylene blue2件: Methylene blue; Methylthioninium chloride; --3件: 46, 97, 127
359 Macimorelin 1件: Macimorelin2件: Macimorelin; Macrilen; 1件: GHSR 💬3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78
360 Mipsagargin -0件: ---
361 Motolimod -0件: ---
362 Maralixibat 1件: Maralixibat1件: Maralixibat; 2件: SLC10A1,
SLC10A2 💬
2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
363 Mirvetuximab -0件: ---
364 Mirvetuximab soravtansine -0件: ---
365 Mongersen 1件: Mongersen1件: Mongersen; 1件: SMAD7 💬2件: Hippo signaling pathway, TGF-beta signaling pathway 💬2件: 96, 97
366 Murepavadin -0件: ---
367 Mirikizumab 1件: Mirikizumab1件: MIRIKIZUMAB; 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 37, 96, 97
368 Modotuximab -0件: ---
369 Mardepodect -0件: ---
370 Midomafetamine -0件: ---
371 Mirogabalin 1件: Mirogabalin1件: Mirogabalin; 2件: CACNA2D1,
CACNA2D2 💬
7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 70
372 Molibresib -0件: ---
373 Mavelertinib -0件: ---
374 Miransertib -0件: ---
375 Maftivimab -0件: ---
376 Mosunetuzumab 1件: Mosunetuzumab1件: Mosunetuzumab; 2件: CD3E,
MS4A1 💬
11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 49
377 Miridesap 1件: Miridesap1件: Miridesap; --1件: 28
378 Monomethyl fumarate 1件: Monomethyl fumarate2件: Bafiertam; Monomethyl fumarate; --15件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 162, 222, 224, 226, 299
379 Miricorilant -0件: ---
380 Mosedipimod -0件: ---
381 Merestinib -0件: ---
382 Melrilimab -0件: ---
383 Milvexian -0件: ---
384 Magrolimab -0件: ---
385 Melphalan flufenamide 1件: Melphalan flufenamide1件: MELFLUFEN; --1件: 28
386 Molnupiravir -0件: ---
387 Mezagitamab 1件: Mezagitamab1件: Mezagitamab; 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 66
388 Mobocertinib -0件: ---
389 Marsh mallow -0件: ---
390 Molidustat -0件: ---
391 Mavacamten 1件: Mavacamten1件: MAVACAMTEN; 1件: MYH7 💬7件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬1件: 58